首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer & metabolism

缩写:CANCER METAB

ISSN:N/A

e-ISSN:2049-3002

IF/分区:5.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引367
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Parmanand Malvi,Balkrishna Chaube,Shivendra Vikram Singh et al. Parmanand Malvi et al.
Background: Obesity is associated with increased risk, poor prognosis and outcome of therapy, in various cancers. Obesity-associated factors or adipokines, especially leptin and resistin, are purported to promote growth, ...
Natthakan Thongon,Chiara Zucal,Vito Giuseppe D&#x;Agostino et al. Natthakan Thongon et al.
Background: Inhibitors of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in NAD+ biosynthesis from nicotinamide, exhibit anticancer effects in preclinical models. However, continuous exposure to ...
Minhye Shin,Jessica Momb,Dean R Appling Minhye Shin
Background: Folate-dependent one-carbon metabolism provides one-carbon units for several biological processes. This pathway is highly compartmentalized in eukaryotes, with the mitochondrial pathway producing formate for u...
Allison N Lau,William J Israelsen,Jatin Roper et al. Allison N Lau et al.
Background: Cancer cells express the M2 isoform of the glycolytic enzyme pyruvate kinase (PKM2). PKM2 expression is not required for some cancers, and PKM2 loss can promote cancer progression; however, PKM2 has been repor...
Caroline H Johnson,Antonio F Santidrian,Sarah E LeBoeuf et al. Caroline H Johnson et al.
Background: Cancer cells that enter the metastatic cascade require traits that allow them to survive within the circulation and colonize distant organ sites. As disseminating cancer cells adapt to their changing microenvi...
Mahya Mehrmohamadi,Seong Ho Jeong,Jason W Locasale Mahya Mehrmohamadi
Background: Antimetabolite chemotherapeutic agents that target cellular metabolism are widely used in the clinic and are thought to exert their anti-cancer effects mainly through non-specific cytotoxic effects. However, p...
Esther A Zaal,Wei Wu,Gerrit Jansen et al. Esther A Zaal et al.
Background: The proteasome inhibitor bortezomib (BTZ) is successfully applied in the treatment of multiple myeloma, but its efficacy is restricted by the wide-spread occurrence of resistance. Metabolic alterations play an...
Nathan J Lanning,Joshua P Castle,Simar J Singh et al. Nathan J Lanning et al.
Background: Among breast cancers, the triple-negative breast cancer (TNBC) subtype has the worst prognosis with no approved targeted therapies and only standard chemotherapy as the backbone of systemic therapy. Unique met...
Petra Miikkulainen,Heidi Högel,Krista Rantanen et al. Petra Miikkulainen et al.
Background: A key feature of clear cell renal cell carcinoma (ccRCC) is the inactivation of the von Hippel-Lindau tumour suppressor protein (pVHL) that leads to the activation of hypoxia-inducible factor (HIF) pathway als...
Loreta M Rodrigues,Santiago Uribe-Lewis,Basetti Madhu et al. Loreta M Rodrigues et al.
Background: Ketone bodies have both metabolic and epigenetic roles in cancer. In several studies, they showed an anti-cancer effect via inhibition of histone deacetylases; however, other studies observed faster tumour gro...